{"id":"https://openalex.org/W2079723218","doi":"https://doi.org/10.1097/qai.0b013e318262514f","title":"CD4, Viral Load Response, and Adherence Among Antiretroviral-Naive Breast-feeding Women Receiving Triple Antiretroviral Prophylaxis for Prevention of Mother-to-Child Transmission of HIV in Kisumu, Kenya","display_name":"CD4, Viral Load Response, and Adherence Among Antiretroviral-Naive Breast-feeding Women Receiving Triple Antiretroviral Prophylaxis for Prevention of Mother-to-Child Transmission of HIV in Kisumu, Kenya","publication_year":2012,"publication_date":"2012-10-01","ids":{"openalex":"https://openalex.org/W2079723218","doi":"https://doi.org/10.1097/qai.0b013e318262514f","mag":"2079723218","pmid":"https://pubmed.ncbi.nlm.nih.gov/22692094"},"language":"en","primary_location":{"id":"doi:10.1097/qai.0b013e318262514f","doi":"https://doi.org/10.1097/qai.0b013e318262514f","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qai.0b013e318262514f","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031063922","display_name":"Jully A. Okonji","orcid":"https://orcid.org/0000-0001-9363-101X","observed_orcids":["https://orcid.org/0000-0001-9363-101X"]},"institutions":[{"id":"https://openalex.org/I2841861","display_name":"Kenya Medical Research Institute","ror":"https://ror.org/04r1cxt79","country_code":"KE","type":"facility","lineage":["https://openalex.org/I2841861"]}],"countries":["KE"],"is_corresponding":true,"raw_author_name":"Jully A. Okonji","raw_affiliation_strings":["Centre for Global Health Research, Kenya Medical Research Institute/US CDC Research and Public Health, Kisumu, Kenya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Global Health Research, Kenya Medical Research Institute/US CDC Research and Public Health, Kisumu, Kenya","institution_ids":["https://openalex.org/I2841861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078706099","display_name":"Clement E. Zeh","orcid":"https://orcid.org/0000-0002-5023-0336","observed_orcids":["https://orcid.org/0000-0002-5023-0336"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I4210145675","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/047h8wb98","country_code":"KE","type":"government","lineage":["https://openalex.org/I4210145675"]}],"countries":["KE","US"],"is_corresponding":false,"raw_author_name":"Clement Zeh","raw_affiliation_strings":["Clement Zeh, PhD, US Centers for Disease Control and Prevention, Kenya, Off Kisumu\u2013Busia Highway, PO Box 1578-40100, Kisumu, Kenya (e-mail: [email\u00a0protected])","US Centers for Disease Control and Prevention, Kisumu, Kenya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Clement Zeh, PhD, US Centers for Disease Control and Prevention, Kenya, Off Kisumu\u2013Busia Highway, PO Box 1578-40100, Kisumu, Kenya (e-mail: [email\u00a0protected])","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I4210145675"]},{"raw_affiliation_string":"US Centers for Disease Control and Prevention, Kisumu, Kenya","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I4210145675"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111745687","display_name":"Paul J. Weidle","orcid":"https://orcid.org/0000-0003-3174-3993","observed_orcids":["https://orcid.org/0000-0003-3174-3993"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paul J. Weidle","raw_affiliation_strings":["Division of HIV/AIDS and Prevention, Surveillance and Epidemiology, National Centers for Disease Control and Prevention, Atlanta, GA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of HIV/AIDS and Prevention, Surveillance and Epidemiology, National Centers for Disease Control and Prevention, Atlanta, GA","institution_ids":["https://openalex.org/I1289490764"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057849978","display_name":"John M Williamson","orcid":"https://orcid.org/0000-0001-8169-1605","observed_orcids":["https://orcid.org/0000-0001-8169-1605"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I4210145675","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/047h8wb98","country_code":"KE","type":"government","lineage":["https://openalex.org/I4210145675"]}],"countries":["KE","US"],"is_corresponding":false,"raw_author_name":"John Williamson","raw_affiliation_strings":["US Centers for Disease Control and Prevention, Kisumu, Kenya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Centers for Disease Control and Prevention, Kisumu, Kenya","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I4210145675"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073255626","display_name":"Benta Akoth","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2841861","display_name":"Kenya Medical Research Institute","ror":"https://ror.org/04r1cxt79","country_code":"KE","type":"facility","lineage":["https://openalex.org/I2841861"]}],"countries":["KE"],"is_corresponding":true,"raw_author_name":"Benta Akoth","raw_affiliation_strings":["Centre for Global Health Research, Kenya Medical Research Institute/US CDC Research and Public Health, Kisumu, Kenya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Global Health Research, Kenya Medical Research Institute/US CDC Research and Public Health, Kisumu, Kenya","institution_ids":["https://openalex.org/I2841861"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111885223","display_name":"Rose O. Masaba","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2841861","display_name":"Kenya Medical Research Institute","ror":"https://ror.org/04r1cxt79","country_code":"KE","type":"facility","lineage":["https://openalex.org/I2841861"]}],"countries":["KE"],"is_corresponding":true,"raw_author_name":"Rose O. Masaba","raw_affiliation_strings":["Centre for Global Health Research, Kenya Medical Research Institute/US CDC Research and Public Health, Kisumu, Kenya","Family Health International, Nairobi, Kenya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Centre for Global Health Research, Kenya Medical Research Institute/US CDC Research and Public Health, Kisumu, Kenya","institution_ids":["https://openalex.org/I2841861"]},{"raw_affiliation_string":"Family Health International, Nairobi, Kenya","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5105834577","display_name":"Mary Glenn Fowler","orcid":"https://orcid.org/0000-0003-4484-9009","observed_orcids":["https://orcid.org/0000-0003-4484-9009"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]},{"id":"https://openalex.org/I4210121676","display_name":"MUJHU Research Collaboration","ror":"https://ror.org/02ee2kk58","country_code":"UG","type":"facility","lineage":["https://openalex.org/I4210121676"]},{"id":"https://openalex.org/I4210145675","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/047h8wb98","country_code":"KE","type":"government","lineage":["https://openalex.org/I4210145675"]}],"countries":["KE","UG","US"],"is_corresponding":false,"raw_author_name":"Mary G. Fowler","raw_affiliation_strings":["Department of Pathology, Johns Hopkins Medical Institute, Baltimore, MD, Onsite at Makerere University, Johns Hopkins University Research Collaboration, Kampala, Uganda","US Centers for Disease Control and Prevention, Kisumu, Kenya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pathology, Johns Hopkins Medical Institute, Baltimore, MD, Onsite at Makerere University, Johns Hopkins University Research Collaboration, Kampala, Uganda","institution_ids":["https://openalex.org/I2799853436","https://openalex.org/I4210121676"]},{"raw_affiliation_string":"US Centers for Disease Control and Prevention, Kisumu, Kenya","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I4210145675"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5074466150","display_name":"Timothy K. Thomas","orcid":"https://orcid.org/0000-0001-9958-8411","observed_orcids":["https://orcid.org/0000-0001-9958-8411"]},"institutions":[{"id":"https://openalex.org/I1289490764","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12","country_code":"US","type":"government","lineage":["https://openalex.org/I1289490764","https://openalex.org/I1299022934"]},{"id":"https://openalex.org/I4210145675","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/047h8wb98","country_code":"KE","type":"government","lineage":["https://openalex.org/I4210145675"]}],"countries":["KE","US"],"is_corresponding":false,"raw_author_name":"Timothy K. Thomas","raw_affiliation_strings":["US Centers for Disease Control and Prevention, Arctic Investigations Program, Anchorage, AK","US Centers for Disease Control and Prevention, Kisumu, Kenya"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"US Centers for Disease Control and Prevention, Arctic Investigations Program, Anchorage, AK","institution_ids":["https://openalex.org/I1289490764"]},{"raw_affiliation_string":"US Centers for Disease Control and Prevention, Kisumu, Kenya","institution_ids":["https://openalex.org/I1289490764","https://openalex.org/I4210145675"]}]}],"institutions":[],"countries_distinct_count":3,"institutions_distinct_count":5,"corresponding_author_ids":["https://openalex.org/A5031063922","https://openalex.org/A5073255626","https://openalex.org/A5111885223"],"corresponding_institution_ids":["https://openalex.org/I2841861"],"apc_list":null,"apc_paid":null,"fwci":1.8563,"has_fulltext":false,"cited_by_count":49,"citation_normalized_percentile":{"value":0.84664409,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"61","issue":"2","first_page":"249","last_page":"257"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.0012000000569969416,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/prevention-of-mother-to-child-transmission","display_name":"prevention of mother-to-child transmission","score":0.8370000123977661},{"id":"https://openalex.org/keywords/antiretroviral-prophylaxis","display_name":"antiretroviral prophylaxis","score":0.8970000147819519},{"id":"https://openalex.org/keywords/triple-antiretroviral-therapy","display_name":"triple antiretroviral therapy","score":0.7879999876022339},{"id":"https://openalex.org/keywords/hiv-viral-suppression","display_name":"HIV viral suppression","score":0.5440000295639038},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.9350000023841858},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.7749999761581421},{"id":"https://openalex.org/keywords/nevirapine","display_name":"nevirapine","score":0.9039999842643738},{"id":"https://openalex.org/keywords/nelfinavir","display_name":"nelfinavir","score":0.9980000257492065},{"id":"https://openalex.org/keywords/postpartum-period","display_name":"postpartum period","score":0.4729999899864197},{"id":"https://openalex.org/keywords/baseline-viral-load","display_name":"baseline viral load","score":0.6819999814033508},{"id":"https://openalex.org/keywords/who-guidelines","display_name":"WHO guidelines","score":0.4790000021457672}],"concepts":[{"id":"https://openalex.org/C2779130552","wikidata":"https://www.wikidata.org/wiki/Q263713","display_name":"Nevirapine","level":5,"score":0.9070005416870117},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8991745710372925},{"id":"https://openalex.org/C2776283161","wikidata":"https://www.wikidata.org/wiki/Q174876","display_name":"Breastfeeding","level":2,"score":0.7630602121353149},{"id":"https://openalex.org/C2777869810","wikidata":"https://www.wikidata.org/wiki/Q422631","display_name":"Lamivudine","level":4,"score":0.6627041697502136},{"id":"https://openalex.org/C2780216070","wikidata":"https://www.wikidata.org/wiki/Q198504","display_name":"Zidovudine","level":4,"score":0.640424370765686},{"id":"https://openalex.org/C142462285","wikidata":"https://www.wikidata.org/wiki/Q2528140","display_name":"Viral load","level":3,"score":0.6130494475364685},{"id":"https://openalex.org/C3020294031","wikidata":"https://www.wikidata.org/wiki/Q174876","display_name":"Breast feeding","level":2,"score":0.583708643913269},{"id":"https://openalex.org/C2781160516","wikidata":"https://www.wikidata.org/wiki/Q423366","display_name":"Nelfinavir","level":5,"score":0.4936860501766205},{"id":"https://openalex.org/C2779234561","wikidata":"https://www.wikidata.org/wiki/Q11995","display_name":"Pregnancy","level":2,"score":0.4865533411502838},{"id":"https://openalex.org/C131872663","wikidata":"https://www.wikidata.org/wiki/Q5284418","display_name":"Obstetrics","level":1,"score":0.46156376600265503},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.34142446517944336},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3158280849456787},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.311662495136261},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.24984866380691528},{"id":"https://openalex.org/C2780727368","wikidata":"https://www.wikidata.org/wiki/Q1928978","display_name":"Viral disease","level":3,"score":0.18765217065811157},{"id":"https://openalex.org/C2993143319","wikidata":"https://www.wikidata.org/wiki/Q583050","display_name":"Antiretroviral therapy","level":4,"score":0.17985135316848755},{"id":"https://openalex.org/C2522874641","wikidata":"https://www.wikidata.org/wiki/Q808","display_name":"Virus","level":2,"score":0.09672102332115173},{"id":"https://openalex.org/C2780593183","wikidata":"https://www.wikidata.org/wiki/Q6844","display_name":"Hepatitis B virus","level":3,"score":0.07547849416732788},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D001942","descriptor_name":"Breast Feeding","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007630","descriptor_name":"Kenya","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000635","qualifier_name":"transmission","is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016903","descriptor_name":"Drug Monitoring","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D018445","descriptor_name":"Infectious Disease Transmission, Vertical","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018890","descriptor_name":"Chemoprevention","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D019562","descriptor_name":"Viral Load","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":"Q000379","qualifier_name":"methods","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1097/qai.0b013e318262514f","doi":"https://doi.org/10.1097/qai.0b013e318262514f","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qai.0b013e318262514f","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},{"id":"pmid:22692094","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/22692094","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of acquired immune deficiency syndromes (1999)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W1853316423","https://openalex.org/W1967223378","https://openalex.org/W1969342241","https://openalex.org/W1973708179","https://openalex.org/W1983300335","https://openalex.org/W1984759630","https://openalex.org/W1997019560","https://openalex.org/W1997808475","https://openalex.org/W1997894781","https://openalex.org/W1998102826","https://openalex.org/W1999846706","https://openalex.org/W2008729344","https://openalex.org/W2015708404","https://openalex.org/W2018044554","https://openalex.org/W2020705331","https://openalex.org/W2034781169","https://openalex.org/W2037152818","https://openalex.org/W2038131962","https://openalex.org/W2042509763","https://openalex.org/W2046785503","https://openalex.org/W2049137163","https://openalex.org/W2056961960","https://openalex.org/W2062352285","https://openalex.org/W2062776174","https://openalex.org/W2064309577","https://openalex.org/W2087309699","https://openalex.org/W2090602501","https://openalex.org/W2093376126","https://openalex.org/W2100049335","https://openalex.org/W2101275320","https://openalex.org/W2110943389","https://openalex.org/W2115037580","https://openalex.org/W2123764335","https://openalex.org/W2148539180","https://openalex.org/W2163018275","https://openalex.org/W2165826479","https://openalex.org/W2171141994","https://openalex.org/W2318289184","https://openalex.org/W2332889087"],"related_works":["https://openalex.org/W2165826479","https://openalex.org/W2745048684","https://openalex.org/W798786276","https://openalex.org/W4297519686","https://openalex.org/W2555080176","https://openalex.org/W2601019410","https://openalex.org/W2136845149","https://openalex.org/W2327614445","https://openalex.org/W7166824523","https://openalex.org/W2181464948"],"abstract_inverted_index":{"BACKGROUND:":[0],"Health":[1],"benefits":[2,32],"and":[3,41,49,61,80,91,117,155,199,217,232],"survival":[4],"of":[5,25,59,141,157,201,212,221,258,266],"an":[6],"exclusively":[7],"breast-fed":[8],"infant":[9],"is":[10],"dependent":[11],"on":[12],"the":[13,17,39,66,101,129,251],"mother's":[14],"health;":[15],"thus,":[16],"need":[18],"for":[19,23,237,242,255,261,263],"antiretroviral":[20],"(ARV)":[21],"intervention":[22],"prevention":[24],"mother-to-child":[26],"transmission":[27],"(PMTCT).":[28],"Achieving":[29],"maternal":[30,54,267],"health":[31],"from":[33,149,167],"these":[34],"regimens":[35],"requires":[36],"adherence":[37,50,122,137,218],"to":[38,153,172,183,235,244],"treatments":[40],"close":[42],"monitoring.":[43],"We":[44,71,120],"evaluated":[45],"virologic,":[46],"immunologic":[47],"responses,":[48],"among":[51,95],"women":[52,97,142],"receiving":[53],"triple":[55],"ARV":[56,259],"prophylaxis":[57,260],"consisting":[58],"lamivudine/zidovudine":[60],"nevirapine":[62],"or":[63],"nelfinavir":[64],"in":[65,77,100],"Kisumu":[67],"Breastfeeding":[68],"Study.":[69],"METHODS:":[70],"analyzed":[72],"baseline":[73,152,171,190,230],"demographic":[74],"data,":[75],"trends":[76],"CD4":[78,160],"count,":[79],"viral":[81],"load":[82],"(VL)":[83],"at":[84,103,151,170,175],"enrollment":[85],"(32-34":[86],"weeks":[87,93,105,177],"gestation),":[88],"delivery,":[89],"14":[90],"24":[92,104,176],"postpartum":[94],"434":[96,130],"who":[98],"remained":[99],"study":[102],"postpartum.":[106,178],"Adherence":[107],"rates":[108],"were":[109],"determined":[110],"using":[111],"pill":[112],"counts":[113],"reinforced":[114],"by":[115],"self-report":[116],"drug":[118],"calendar.":[119],"dichotomized":[121],"as":[123],"\u226595%":[124],"versus":[125,203],"<95%.":[126],"RESULTS:":[127],"Among":[128],"women,":[131],"84%":[132],"(n":[133],"=":[134,224],"366)":[135],"had":[136],"\u226595%.":[138],"The":[139],"proportion":[140],"with":[143,159,189,210,219],"undetectable":[144,208,246],"VL":[145,185,191,209,222,231],"(<400":[146],"copies/mL)":[147],"increased":[148],"6%":[150],"79%,":[154],"that":[156],"those":[158],"count":[161],"<250":[162],"cells":[163],"per":[164,195],"microliter":[165],"decreased":[166],"23%":[168],"(100)":[169],"5%":[173],"(22)":[174],"In":[179],"discrete-survival":[180],"model,":[181],"time":[182],"achieving":[184],"suppression":[186,220],"was":[187,226],"associated":[188],"<5.0":[192],"log":[193],"copies":[194],"milliliter,":[196],"parity":[197],"\u22652,":[198],"use":[200],"nelfinavir-":[202],"nevirapine-based":[204],"ARV.":[205],"Association":[206],"between":[207],"duration":[211],"therapy":[213],"(P":[214,223],"<":[215],"0.0001)":[216],"0.001)":[225],"observed.":[227],"CONCLUSIONS:":[228],"High":[229],"short":[233],"exposure":[234],"ARVs":[236],"PMTCT":[238,262],"are":[239],"risk":[240],"factors":[241],"failing":[243],"achieve":[245],"VL.":[247,268],"These":[248],"findings":[249],"support":[250],"new":[252],"WHO":[253],"guidelines":[254],"early":[256],"initiation":[257],"maximal":[264],"reduction":[265]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":6},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":4},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":10},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":1},{"year":2013,"cited_by_count":4}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}